DIVISLABNSEDivi's Laboratories Limited· PharmaceuticalsHighNeutral
Announced Sat, 23 May · 12:17 IST

Divi's Laboratories Limited has informed the Exchange that Record date for the purpose of Dividend is 24-Jul-2026.

Corporate Actions View source PDF

DIVISLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-2.3%1-day move
₹6900.00
prior close
₹6750.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.1+1.4+1.1+2.0-2.3-1.6-3.2-5.0-5.7-4.6-2.5-2.9+7.8
Up moveDown movePending
AI summary

Divi's Laboratories reported strong FY2026 results with consolidated total income of ₹11,067 crores, up 13.9% YoY from ₹9,712 crores. Consolidated PAT grew to ₹2,568 crores versus ₹2,191 crores in the prior year, reflecting robust operational performance. The Board recommended a final dividend of ₹30 per equity share (1500% on face value of ₹2) for FY2025-26, subject to shareholder approval at the 36th AGM on August 10, 2026. The record date for dividend entitlement is July 24, 2026. The company also absorbed a one-time ₹74 crore exceptional charge related to new labour code implementation, which impacted PBT by that amount.

Likely market impact

Strong earnings growth and a generous 1500% dividend payout signal confidence in the business and provide positive support for the stock, with the July 24 record date being the key date for shareholders to be eligible for the dividend.